ASCO-GI 2020, poster

Isofol will attend the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO-GI), that is being held from January 23 – 25, 2020, in San Francisco. The presentation and poster presents details in the ongoing global Phase 3 AGENT clinical study (ISO-CC-007).

Information about the presentationen

Title: ”AGENT: An open-label Phase III study of arfolitixorin vs leucovorin in modified FOLFOX-6 for first-line treatment of metastatic colorectal cancer”

Authors: Heinz-Josef Lenz, Peter Gibbs, Sebastian Stintzing, Gerald W. Prager, Peter Nygren, Christos A. Papadimitriou, Roger Tell, Takayuki Yoshino, Derek J. Jonker, Aimery De Gramont, Josep Tabernero

Presentation Number: TPS268

Presentation Date: January 25

Presentation Time: 6:30 a.m. – 7:55 a.m (Pacific Time)

Speaker: Heinz-Josef Lenz

Session: Trials in Progress Poster Session C: Anal and Colorectal Cancer

The poster will be available below at the same time:

The poster will be published after the congress and will also be available below: